Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, randomized, double-blind, parallel, phase IV study
designed to evaluate the safety and efficacy of sovateltide (PMZ-1620, IRL-1620) as a
potential treatment for cerebral ischemic stroke.